Advertisement

Opzelura – SEP Display Banners HCP Wallboard Extension – 34626

Assessing the Association Between Vitiligo & Mental Health

Vitiligo, a chronic condition characterized by loss of skin pigmentation, can impact patients’ psychological wellbeing, according to clinical research. Studies show that vitiligo has been associated with generalized anxiety and...

Pediatric Patients With Vitiligo Respond Well to 308-nm Laser

Pediatric patients with vitiligo responded well to 308-nm laser treatment, with the best retention of re-pigmentation for facial lesions, according to a study published in the Journal of Drugs and Dermatology. Sumit Sethi, MBBS,...

Vitiligo Awareness & Attitudes Vary by Ethnicity

Among different ethnic groups, knowledge of and attitudes toward vitiligo varies, according to a study published in the Journal of Cosmetic Dermatology. Premjit Juntongjin, MD, and colleagues assessed knowledge and attitudes...

First Topical Vitiligo Treatment Approved

The FDA has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo. The 1.5% cream is approved for continuous topical use twice daily to affected areas of up to 10% of body surface area in patients aged 12...

Why Diversity & Inclusion Are Needed in Medicine

In a recent Wall Street Journal article, the authors equate teaching future doctors about “diversity, equity, and inclusion competencies” to “political re-education” and “wokeness.” They claim that “hyper-class and -racial...

Loading

Advertisement

For latest news and updates
Email-id is invalid